Registration and Continental Breakfast
Welcome and Opening Remarks
Chronic Kidney Disease (CKD) as a Public Health Crisis
CKD is a growing epidemic in the United States and worldwide. Morbidity and mortality among patients with CKD are high as are costs associated with care, which is highly fragmented. This presentation will address the growing magnitude of CKD incidence, highlight challenges to meeting evidence-based guidelines, and identify strategies used in early detection of this “silent” disease.
- Review the increased incidence of CKD.
- Discuss challenges to meeting the evidence-based guidelines for CKD.
- Identify strategies for early detection of CKD.
Management Strategies for CKD Patients
With 73 million Americans at risk for kidney disease due to diabetes, high blood pressure, or a family history of kidney failure, and more than 415,000 people in the United States dependent on dialysis treatment to survive, a management plan should include careful coordination of care that addresses strategies to promote patient self-management. This presentation will discuss interventions that can enhance adherence through self-management strategies.
- Discuss interventions that can enhance adherence to promote glycemic control.
- State the key components of a multifaceted treatment plan for self-management strategies.
- List modifiable barriers to self-management.
- Discuss the role of cultural factors that should be considered with self-management.
A New Approach for Evaluating Renal Function and Predicting Risk
Currently, kidney disease severity can be classified by estimated glomerular filtration rate (eGFR) and albuminuria, but more accurate information regarding risk for progression to kidney failure is required for clinical decisions about testing, treatment, and referral. A new international study from the Chronic Kidney Disease Prognosis Consortium found that using cystatin C blood levels to estimate kidney function—alone or in combination with creatinine—strengthens the association between kidney function and risks of death and ESRD. This presentation will discuss improved methods for identifying the subset of patients who are at the highest risk of adverse outcomes and how this could be useful for clinicians and other decision-makers.
- Evaluate whether combining creatinine, cystatin C, and urine albumin-to-creatinine ratio (ACR) would improve identification of risks associated with CKD compared with creatinine alone.
- Describe the patient populations that would most benefit from using cystatin C in GFR estimating equations.
- Review whether cystatin C has the potential to make eGFR more accurate.
- Discuss the limitations of eGFR alone for predicting the risk of CKD.
Reducing Cardiovascular Risk for Patients With CKD
Over the last decade, the nephrology community has come to recognize the importance of cardiovascular risk for patients with CKD. Early identification and treatment of CKD may impact cardiovascular morbidity and mortality in patients with CKD by reducing risk. This presentation will discuss approaches to reduce risk and prevent cardiovascular events in CKD patients.
- Discuss how to reduce cardiovascular risk in CKD patients.
- Review the recommendations for dyslipidemia management for patients with CKD.
- Discuss the value of cholesterol-lowering therapies in kidney disease.
Luncheon Presentation—An Overview of Optum™ (optional; lunch provided)
Outcomes of Early vs. Late Nephrology Referral in CKD
Timely referral to a nephrologist for the management of CKD is of critical importance—late referral can result in serious consequences. Patients with ESRD experience significant morbidity, including a substantial decline in quality of life. Mortality is high despite improvements in the overall quality of dialysis therapy and increased healthcare expenditures. Patients with CKD are referred to nephrologists either early (usually for help in diagnostic and management issues) or late (referral is usually considered late if patient is referred just before requiring renal replacement therapy) in their clinical course. The late referral of patients with CKD may adversely affect outcomes for dialysis patients, in part due to the suboptimal management of complications associated with kidney failure. This presentation will review the impact of timely referrals to a nephrologist and the initiation of renal replacement therapy in patients with CKD.
- State potential benefits of timely referral to a nephrologist.
- Discuss the reasons for and consequences of late referral to a nephrologist.
- Identify indications and effective strategies for late-referral patients.
- Review clinical practice guidelines regarding indications for referral of CKD patients to a nephrologist.
Epidemic of Childhood Obesity: Implications for Kidney Disease
Obesity has been recognized as a risk factor for the development and progression of CKD. We have seen the prevalence of ESRD rise dramatically in the past decade in parallel with the increase in obesity. Childhood obesity has become a global epidemic with many long-term adverse effects on morbidity and mortality. This presentation will address childhood obesity as a risk factor for CKD.
- Discuss the epidemiology of obesity and CKD.
- State the risk factors of childhood obesity.
- Describe the impact of childhood obesity and kidney disease.
CKD in Pediatrics: Management Strategies for Long-Term Complications and Transition to Adult Care Settings
CKD is much more common in adults than in children, but the incidence of CKD in children has increased steadily over the past two decades. The treatment of CKD in this age group presents unique challenges. Among those challenges are the management of several comorbid conditions such as anemia, growth and nutrition, bone and mineral disorders, and cardiovascular complications, as well as the transition to adult care settings. This presentation will discuss management strategies for long-term complications in pediatric patients and address the evolving field of “transition medicine” as complex pediatric patients transition to adult care.
- Discuss management strategies for long-term complications in pediatric patients with kidney disease.
- Review therapeutic strategies for optimizing nutrition and growth in children with CKD.
- Identify modifiable risk factors for CKD.
- Describe “transition medicine” as it relates to complex pediatric patients' transition to the adult care setting.
Palliative Care: ESRD
Palliative care refers to the comprehensive management of the physical, psychological, social, and spiritual needs of the patients and their families in the setting of serious illness. Providing palliative care to patients with CKD begins at diagnosis and continues throughout the patient's life. This presentation will discuss approaches to care planning and various tools that have been used to assess patients' quality of life.
- Identify patients for whom palliative care is appropriate.
- Describe approaches to care planning in minority populations.
- Discuss the importance of collaboration between renal, palliative, and primary care services to ensure a whole systems approach and avoid unnecessary hospital admissions.
Complimentary Get-Acquainted Reception
Join your colleagues for hors d’oeuvres and beverages. You won’t want to miss this opportunity to gather information and ideas from exhibitors regarding the management of kidney disease and other complex medical conditions.